predisposition to coronary heart disease

Báo cáo y học: "Association of the T+294C polymorphism in PPAR δ with low HDL cholesterol and coronary heart disease risk in women"

Báo cáo y học: "Association of the T+294C polymorphism in PPAR δ with low HDL cholesterol and coronary heart disease risk in women"

Ngày tải lên : 31/10/2012, 17:03
... Packard CJ, Ehrenborg E. Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men. J Int ... CM, Gotto AM, Marian AJ. Effects of PPARα, γ and δ haplotypes on plasma levels of lipids and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary ... (C). 4. Discussion and Conclusions To address the question whether the +T294C polymorphism in PPARδ is associated with the risk for coronary heart disease and/or plasma lipid levels in women,...
  • 4
  • 568
  • 0
coronary heart disease  -  clin., pathol., imaging, molec. profiles  -  z. vlodaver, et. al., (springer, 2012)

coronary heart disease - clin., pathol., imaging, molec. profiles - z. vlodaver, et. al., (springer, 2012)

Ngày tải lên : 12/05/2014, 17:13
... Garry Editors Coronary Heart Disease Clinical, Pathological, Imaging, and Molecular Profiles 151 Anatomy of Coronary Vessels septum is supplied by branches arising from both the right coronary ... the heart tube to contribute to the connective tissue of the myocardium and epicardium and give rise to the coronary arteries [ 6, 7 ] . Chapter 2 Cardiac Development and Congenital Heart Disease ... second heart field onto the outflow tract. This process is regulated by global cardiac transcription factors including Nkx2-5 , Gata4 , and transcription factors specific to the second heart...
  • 557
  • 980
  • 0
báo cáo hóa học:" Structural ambiguity of the Chinese version of the hospital anxiety and depression scale in patients with coronary heart disease" doc

báo cáo hóa học:" Structural ambiguity of the Chinese version of the hospital anxiety and depression scale in patients with coronary heart disease" doc

Ngày tải lên : 20/06/2014, 15:20
... exploratory factor analysis should be used to determine the original factor structure of an instrument, and confirmatory factor analysis used to determine how well an a priori-defined factor structure fits ... literature to see exploratory factor analysis used to investigate the factor structure of an instrument that has previously been investigated using exploratory factor analysis. Consequently, exploratory ... (HADS) is a widely used screening tool designed as a case detector for clinically relevant anxiety and depression. Recent studies of the HADS in coronary heart disease (CHD) patients in European...
  • 5
  • 392
  • 0
báo cáo hóa học:" Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease" pdf

báo cáo hóa học:" Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease" pdf

Ngày tải lên : 20/06/2014, 15:20
... completed prior to intervention and 1, 3, 6 and 12 months post-intervention in a study enrolling 561 patients with symptomatic coronary stenosis. Patients were randomized to off-pump coronary artery ... the OctoStent off-pump CABG group; changes in the Octopump groups are comparable to this group and therefore omitted from the table Histogram of baseline EQ-5D and SF-6D scoresFigure 2 Histogram ... symptomatic coronary sten- osis. Methods We included patients with symptomatic coronary stenosis enrolled in two multicenter randomized controlled trials assessing the efficacy of the Octopus...
  • 9
  • 408
  • 0
báo cáo hóa học:" Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease" pptx

báo cáo hóa học:" Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease" pptx

Ngày tải lên : 20/06/2014, 16:20
... patients have roughly correspond to their dis- ease severity, so it was important to take the disease stage into account when trying to map from disease specific variables to the EQ-5D index. Several ... Mapping models may need to be derived sepa- rately for different disease groups, since the most effec- tive predictors may vary between diseases. Also, mapping models need to incorporate variables ... groups, including those with coronary heart disease. Studies often require patients to complete many questionnaires and the EQ-5D may not be gathered. This study aimed to assess whether demographic...
  • 13
  • 334
  • 0
N-Terminal Pro–B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease ppt

N-Terminal Pro–B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease ppt

Ngày tải lên : 27/06/2014, 00:20
... associated with coronary heart disease. 9,10 However, unlike previous investigators, we used an- giographically diagnosed coronary artery disease to define existing coronary heart disease. Patients ... mortality in stable coronary disease 671 end-diastolic pressure, and were more likely to have a history of myocardial infarction, clinically signifi- cant coronary artery disease, and diabetes; ... findings (%) <0.001 No coronary artery disease 31 19 14 16 1-Vessel disease 28 21 13 18 2-Vessel disease 19 24 23 19 3-Vessel disease 15 26 40 36 Left main coronary artery disease 7 10 10 11 LVEF...
  • 11
  • 353
  • 0
Báo cáo y học: "Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turk

Báo cáo y học: "Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turk

Ngày tải lên : 25/10/2012, 11:18
... re- peated boli administered as needed to maintain acti- vated and clotting time of 250 to 300 s. Patients re- ceived intracoronary nitroglycerin (0.1 to 0.2 mg) to achieve maximal vasodilatation ... Med. Sci. 2011, 8 http://www.medsci.org 69 (BMSs) in patients with symptomatic coronary artery disease of simple to moderate complexity (1-3). The use of the Zotarolimus-eluting stent (ZES; ... angiographic restenosis in patients with symptomatic coronary ar- tery disease (CAD; 4). Also the safety and efficacy of Paclitaxel-eluting stent (PES; Taxus, Boston Scientific Corp., Natick, Massachusetts)...
  • 6
  • 550
  • 0
Báo cáo y học: "Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey&

Báo cáo y học: "Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey&

Ngày tải lên : 26/10/2012, 08:57
... Caputo RP, et al.; for the SIRIUS Investiga- tors. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323 2. Stone ... analyzed data on a consecutive series of all patients who presented to our institution with symptomatic coronary artery disease between February 2005 and March 2007 and who were treated with ... Abbreviations: CABG, coronary artery bypass graft; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MI, myocardial infarc- tion; SAP, stable angina pectoris; USAP, unstable angina pectoris. a Indicates...
  • 6
  • 627
  • 0
Advances in StentTherapy for Ischaemic Heart Disease

Advances in StentTherapy for Ischaemic Heart Disease

Ngày tải lên : 26/01/2013, 11:02
... Mak Heart Pharmacologic Approaches Anti-inflammatory Immunomodulators Anti-proliferative Migration inhibitors ECM-modulators Promote healing and reendothelisation Dexamethasone M-prednisolone Interferon ... Taxol Actinomycin Methothrexate Angiopeptin Vincristine Mitomycine Statins C-myc antisense Sirolimus (& analogs) RestenASE 2-chloro- deoxyadenosine PCNA Ribozyme Batimastat Prolyl hydroxylase inhibitors Halofuginone C-proteinase inhibitors Probucol BCP671 VEGF Estradiols NO ... actions Mak Heart Stent-based Drug Delivery Cordis GuidantCook Boston Scientific BiodiYsio Matrix LO ++++++ + BiodiYsio Matrix HI JoMed Sorin BionsensorsConor Medsytems Igaki-Tamai Mak Heart 10.4 5.0 4.7 4.8 1.8 9.2 11.5 5.4 4.6 5.5 1.2 10.6 0 2 4 6 8 10 12 14 MACE...
  • 38
  • 375
  • 0

Xem thêm